Alzheimer’s and Parkinson’s Disease at AD/PD ’26

Nordic Bioscience´s neurology team has had 4 abstracts and oral presentation accepted at the AD/PD™ Alzheimer’s Disease and Parkinson’s Disease Conference in 2026.

The abstracts cover the following topics:

• Modulation of blood-brain barrier integrity biomarkers in neurological disorders
• Upregulation of serum calprotectin biomarkers in patients with Parkinson’s Disease
• Elevation of type III and IV collagen fragments in the serum of treatment naïve multiple sclerosis patients
• Biomarker profiling for the diagnosis of Parkinson’s disease

Abstracts

Biomarker Profiling for the Diagnosis of PD

Authors: Meryem Benmarce, Signe Holm Nielsen, Kim Henriksen
Presenter: Meryem Benmarce
Abstract ID: 1260
Topic: Theme C: α-Synucleinopathies / C04.f. Imaging, Biomarkers, Diagnostics: skin, CSF-, and blood-based biomarkers

Biomarkers of Blood Brain Barrier Integrity Are Modulated in Neurological Disorders

Authors: Kim Henriksen, Nicholas Willumsen, Signe Holm Nielsen
Presenter: Kim Henriksen
Abstract ID: 1778
Topic: Theme C: α-Synucleinopathies / C04.f. Imaging, Biomarkers, Diagnostics: skin, CSF-, and blood-based biomarkers

The Serum Calprotectin Biomarker Is Upregulated in Patients With Parkinson’s Disease

Authors: Signe Holm Nielsen, Kim Henriksen
Presenter: Signe Holm Nielsen
Abstract ID: 1774
Topic: Theme C: α-Synucleinopathies / C04.f. Imaging, Biomarkers, Diagnostics: skin, CSF-, and blood-based biomarkers

Type III and IV Collagen Fragments Are Elevated in Serum of Treatment-Naïve Multiple Sclerosis Patients

Authors: Anna San Torcuato
Presenter: Anna San Torcuato
Abstract ID: 1628
Topic: Theme H: Demyelinating Diseases / H02. Imaging, Biomarkers, Diagnostics

Oral Presentation

The Blood-Based Biomarker Tau-C Is Related to Neurodegeneration, but Not Neuroinflammation

Authors: Signe Holm Nielsen, Kim Henriksen
Presenter: Kim Henriksen
Location: Auditorium 15
Time: Thursday, March 19, 9:40–9:55